Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1978 Jul;21(1):69–75. doi: 10.1128/iai.21.1.69-75.1978

Protective effect of vaccination against Mycoplasma pulmonis respiratory disease in rats.

G H Cassell, J K Davis
PMCID: PMC421959  PMID: 711323

Abstract

Intravenous vaccination of rats with either viable or Formalin-inactivated Mycoplasma pulmonis reduced the incidence and severity of lower respiratory tract lesions after intranasal challenge with viable organisms. Intranasal vaccination with killed organisms reduced the severity of rhinitis, but did not affect lesions in any other region of the respiratory tract. The maximum protection against upper tract lesions (rhinitis, otitis, and laryngotracheitis) was provided by intravenous immunization with viable organisms. Dual vaccination (intraperitoneal plus intranasal) with killed organisms provided no significant protection in any segment of the tract. However, these ineffective vaccine regimens did not potentiate the lesions. These results conclusively demonstrate that vaccination of rats against mycoplasma respiratory disease is feasible and also suggest that systemic vaccination may provide greater protection for the lungs than intranasal vaccination, at least when equivalent antigen doses are used.

Full text

PDF
69

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Allison A. C. Immunity and immunopathology in virus infections. Ann Inst Pasteur (Paris) 1972 Oct;123(4):585–608. [PubMed] [Google Scholar]
  2. Broderson J. R., Lindsey J. R., Crawford J. E. The role of environmental ammonia in respiratory mycoplasmosis of rats. Am J Pathol. 1976 Oct;85(1):115–130. [PMC free article] [PubMed] [Google Scholar]
  3. Cassell G. H., Lindsey J. R., Baker H. J. Immune response of pathogen-free mice inoculated intranasally with Mycoplasma pulmonis. J Immunol. 1974 Jan;112(1):124–136. [PubMed] [Google Scholar]
  4. Del Giudice R. A., Robillard N. F., Carski T. R. Immunofluorescence identification of Mycoplasma on agar by use of incident illumination. J Bacteriol. 1967 Apr;93(4):1205–1209. doi: 10.1128/jb.93.4.1205-1209.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Denny F. W., Taylor-Robinson D., Allison A. C. The role of thymus-dependent immunity in Mycoplasma pulmonis infections of mice. J Med Microbiol. 1972 Aug;5(3):327–336. doi: 10.1099/00222615-5-3-327. [DOI] [PubMed] [Google Scholar]
  6. Harwick H. J., Kalmanson G. M., Fox M. A., Guze L. B. Arthritis in mice due to infection with Mycoplasma pulmonis. I. Clinical and microbiologic features. J Infect Dis. 1973 Oct;128(4):533–540. doi: 10.1093/infdis/128.4.533. [DOI] [PubMed] [Google Scholar]
  7. Hayflick L. Tissue cultures and mycoplasmas. Tex Rep Biol Med. 1965 Jun;23(Suppl):285+–285+. [PubMed] [Google Scholar]
  8. Hunninghake G. W., Fauci A. S. Immunolgic reactivity of the lung. V. Regulatory effects of antibody on the pulmonary immune response to locally administered antigen. J Immunol. 1977 May;118(5):1728–1733. [PubMed] [Google Scholar]
  9. Jemski J. V., Hetsko C. M., Helms C. M., Grizzard M. B., Walker J. S., Chanock R. M. Immunoprophylaxis of experimental Mycoplasma pneumoniae disease: effect of aerosol particle size and site of deposition of M. pneumoniae on the pattern of respiratory infection, disease, and immunity in hamsters. Infect Immun. 1977 Apr;16(1):93–98. doi: 10.1128/iai.16.1.93-98.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kohn D. F., Kirk B. E. Pathogenicity of Mycoplasma pulmonis in laboratory rats. Lab Anim Care. 1969 Jun;19(3):321–330. [PubMed] [Google Scholar]
  11. Lindsey J. R., Baker H. J., Overcash R. G., Cassell G. H., Hunt C. E. Murine chronic respiratory disease. Significance as a research complication and experimental production with Mycoplasma pulmonis. Am J Pathol. 1971 Sep;64(3):675–708. [PMC free article] [PubMed] [Google Scholar]
  12. Lindsey J. R., Cassell H. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Models for studying mycoplasmosis of the respiratory tract. Am J Pathol. 1973 Jul;72(1):63–90. [PMC free article] [PubMed] [Google Scholar]
  13. Mauel J., Behin R. Cell-mediated and humoral immunity to protozoan infections. Transplant Rev. 1974;19(0):121–146. doi: 10.1111/j.1600-065x.1974.tb00130.x. [DOI] [PubMed] [Google Scholar]
  14. Murray M. Local immunity and its role in vaccination. Vet Rec. 1973 Nov 10;93(19):500–504. doi: 10.1136/vr.93.19.500. [DOI] [PubMed] [Google Scholar]
  15. Organick A. B., Lutsky I. I. Mycoplasma pulmonis infection in gnotobiotic and conventional mice: aspects of pathogenicity including microbial enumeration and studies of tracheal involvement. Lab Anim Sci. 1976 Jun;26(3):419–429. [PubMed] [Google Scholar]
  16. Overcash R. G., Lindsey J. R., Cassel G. H., Baker H. J. Enhancement of natural and experimental respiratory mycoplasmosis in rats by hexamethylphosphoramide. Am J Pathol. 1976 Jan;82(1):171–190. [PMC free article] [PubMed] [Google Scholar]
  17. Pearson H. E. Infection and Immunity in Mouse Catarrh. J Bacteriol. 1942 Feb;43(2):229–235. doi: 10.1128/jb.43.2.229-235.1942. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Taylor G., Howard C. J., Gourlay R. N. Protective effect of vaccines on Mycoplasma pulmonis-induced respiratory disease of mice. Infect Immun. 1977 May;16(2):422–431. doi: 10.1128/iai.16.2.422-431.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Taylor G., Taylor-Robinson D. Effects of active and passive immunization on Mycoplasma pulmonis-induced pneumonia in mice. Immunology. 1976 May;30(5):611–618. [PMC free article] [PubMed] [Google Scholar]
  20. Taylor G., Taylor-Robinson D., Fernald G. W. Reduction in the severity of Mycoplasma pneumoniae-induced pneumonia in hamsters by immunosuppressive treatment with antithymocyte sera. J Med Microbiol. 1974 Aug;7(3):343–348. doi: 10.1099/00222615-7-3-343. [DOI] [PubMed] [Google Scholar]
  21. Thomas W. R., Holt P. G., Keast D. Local and systemic immune response of mice after intratracheal and intravenous inoculations of sheep erythrocytes. Int Arch Allergy Appl Immunol. 1974;46(4):487–497. doi: 10.1159/000231152. [DOI] [PubMed] [Google Scholar]
  22. Waldman R. H., Henney C. S. Cell-mediated immunity and antibody responses in the respiratory tract after local and systemic immunization. J Exp Med. 1971 Aug 1;134(2):482–494. doi: 10.1084/jem.134.2.482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Waldman R. H., Spencer C. S., Johnson J. E., 3rd Respiratory and systemic cellular and humoral immune responses to influenza virus vaccine administered parenterally or by nose drops. Cell Immunol. 1972 Feb;3(2):294–300. doi: 10.1016/0008-8749(72)90168-2. [DOI] [PubMed] [Google Scholar]
  24. Whittlestone P. Immunity to mycoplasmas causing respiratory diseases in man and animals. Adv Vet Sci Comp Med. 1976;20:277–307. [PubMed] [Google Scholar]
  25. Whittlestone P., Lemcke R. M., Olds R. J. Respiratory disease in a colony of rats. II. Isolation of Mycoplasma pulmonis from the natural disease, and the experimental disease induced with a cloned culture of this organism. J Hyg (Lond) 1972 Sep;70(3):387–407. doi: 10.1017/s0022172400062975. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES